1aq7 | TRYPSIN WITH INHIBITOR AERUGINOSIN 98-B |
1auj | BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR |
1az8 | BOVINE TRYPSIN COMPLEXED TO BIS-PHENYLAMIDINE INHIBITOR |
1bju | BETA-TRYPSIN COMPLEXED WITH ACPU |
1bjv | BETA-TRYPSIN COMPLEXED WITH APPU |
1btp | MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: NULL; EC: 3 .4.21.4; HETEROGEN: N-[3-[4-[4-(AMIDINOPHENOXY)- CARBONYL]PHENYL]-2- METHYL-2-PROPENOYL]-N-ALLYLGLYCINE METHANESULFONATE |
1btw | MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: A; EC: 3.4 .21.4; MOL_ID: 2; MOLECULE: T-BUTOXY-ALA-VAL-BORO- LYS 1,3-PROPANEDIOL MONOESTER; CHAIN: H |
1btx | MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: A; EC: 3.4 .21.4; MOL_ID: 2; MOLECULE: T-BUTOXY-ALA-VAL-BORO- LYS ETHYL ESTER; CHAIN: H |
1bty | MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: NULL; EC: 3 .4.21.4; HETEROGEN: BENZAMIDINE |
1btz | MOL_ID: 1; MOLECULE: BETA-TRYPSIN; CHAIN: A; EC: 3.4 .21.4; MOL_ID: 2; MOLECULE: T-BUTOXY-ALA-VAL-BORO- LYS METHYL ESTER; CHAIN: H |
1c1n | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c1o | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c1p | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c1q | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c1r | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c1s | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c1t | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2d | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2e | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2f | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2g | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2h | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2i | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2j | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2k | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OFSERINE PROTEASES |
1c2l | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c2m | RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES |
1c5p | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c5q | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c5r | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c5s | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c5t | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c5u | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c5v | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1c9t | COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN |
1ce5 | BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE |
1cu7 | BOVINE TRYPSIN COMPLEXED WITH 2-[3-AMINO(IMINOMETHYL) PHENOXY]-6-[3-(AMINOMETHYL)PHENOXY]-3,5-DIFLUORO-4- METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS |
1cu8 | BOVINE TRYPSIN COMPLEXED WITH 2,6-BIS[3-AMINO(IMINO )METHYL PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK- 805623), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS |
1cu9 | BOVINE TRYPSIN COMPLEXED WITH 2,6-BIS[3-AMINO(IMINO )METHYL PHENOXY]-3,5-DIFLUORO-4-METHYLPYRIDINE (ZK- 805623), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS |
1d6r | CRYSTAL STRUCTURE OF CANCER CHEMOPREVENTIVE BOWMAN-BIRK INHIBITOR IN TERNARY COMPLEX WITH BOVINE TRYPSIN AT 2 .3 A RESOLUTION. STRUCTURAL BASIS OF JANUS-FACED SERINE PROTEASE INHIBITOR SPECIFICITY |
1eb2 | TRYPSIN INHIBITOR COMPLEX (FRA) |
1ejm | CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN |
1ezx | CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX |
1f0t | BOVINE TRYPSIN COMPLEXED WITH RPR131247 |
1f0u | BOVINE TRYPSIN COMPLEXED WITH RPR128515 |
1f2s | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA- TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION |
1g36 | TRYPSIN INHIBITOR COMPLEX |
1g3b | BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASEMAGNESIUM(II) CHELATE |
1g3c | BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASEIRON(III) CHELATE |
1g3d | BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASECOPPER (II) CHELATE |
1g3e | BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF- BASECOPPER (II) CHELATE |
1g9i | CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE |
1gbt | BETA-TRYPSIN GUANIDINOBENZOYLATED AT SERINE 195 (PH 5. 5) |
1ghz | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi0 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi1 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi2 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi3 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi4 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi5 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gi6 | A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
1gj6 | ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
1hj9 | ATOMIC RESOLUTION STRUCTURES OF TRYPSIN PROVIDE INSIGHT INTO STRUCTURAL RADIATION DAMAGE |
1j8a | CRYSTAL STRUCTURE OF BENZAMIDINE INHIBITED BOVINEPANCREATIC TRYPSIN AT 105K TO 1.21A RESOLUTION FROMLABORATORY SOURCE WITH HIGH NUMBER OF WATERS MODELLED |
1jir | CRYSTAL STRUCTURE OF TRYPSIN COMPLEX WITH AMYLAMINE INCYCLOHEXANE |
1jrs | HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN |
1jrt | HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN |
1k1i | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1k1j | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1k1l | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1k1m | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1k1n | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1k1o | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1k1p | BOVINE TRYPSIN-INHIBITOR COMPLEX |
1lqe | CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79. |
1max | BETA-TRYPSIN PHOSPHONATE INHIBITED |
1may | BETA-TRYPSIN PHOSPHONATE INHIBITED |
1mts | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
1mtu | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
1mtv | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
1mtw | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
1n6x | RIP-PHASING ON BOVINE TRYPSIN |
1n6y | RIP-PHASING ON BOVINE TRYPSIN |
1nc6 | POTENT, SMALL MOLECULE INHIBITORS OF HUMAN MAST CELLTRYPTASE. ANTI-ASTHMATIC ACTION OF A DIPEPTIDE- BASEDTRANSITION STATE ANALOGUE CONTAINING BENZOTHIAZOLE KETONE |
1ntp | MODIFIED BETA TRYPSIN (MONOISOPROPYLPHOSPHORYL INHIBITED) ( NEUTRON DATA) |
1o2h | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2i | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2j | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2k | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2l | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2m | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2n | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2o | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2p | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2q | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2r | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2s | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2t | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2u | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2v | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2w | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2x | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2y | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o2z | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o30 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o31 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o32 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o33 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o34 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o35 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o36 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o37 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o38 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o39 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3a | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3b | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3c | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3d | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3e | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3f | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3g | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3h | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3i | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3j | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3k | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3l | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3m | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3n | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1o3o | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS |
1oph | NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH ANDS195A TRYPSIN |
1ox1 | CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH ASYNTHETIC 11 PEPTIDE INHIBITOR |
1oyq | TRYPSIN INHIBITOR COMPLEX |
1p2i | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINETRYPSIN AND CHYMOTRYPSIN |
1p2j | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINETRYPSIN AND CHYMOTRYPSIN |
1p2k | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINETRYPSIN AND CHYMOTRYPSIN |
1ppc | TRYPSIN COMPLEX WITH NONCOVALENTLY BOUND NAPAP |
1ppe | TRYPSIN COMPLEX WITH (CUCURBITA MAXIMA) TRYPSIN INHIBITOR (CMTI-I) |
1pph | TRYPSIN COMPLEX WITH NONCOVALENTLY BOUND 3-TAPAP |
1qa0 | BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX |
1qb1 | BOVINE TRYPSIN WITH 1-[2-[5-[AMINO(IMINO)METHYL]-2 - HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1-METHYL-1H- IMIDAZOL-2-YL) PHENOXY]PYRIDIN-4-YL]PIPERIDINE-3- CARBOXYLIC ACID (ZK- 806974) |
1qb6 | BOVINE TRYPSIN 3,3'-[3,5-DIFLUORO-4-METHYL-2, 6- PYRIDINEDIYLBIS(OXY)]BIS(BENZENECARBOXIMIDAMIDE) (ZK-805623 ) COMPLEX |
1qb9 | BOVINE TRYPSIN 7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4- YL]OXY]- 9H-CARBOZOL-9-YL] METHYL]NAPHTHALENE-2- CARBOXIMIDAMIDE (ZK- 806450) COMPLEX |
1qbn | BOVINE TRYPSIN 2-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY ]-6- [3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENOXY] PYRIDINE-4- CARBOXYLIC ACID (ZK-806688) COMPLEX |
1qbo | BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4- YL]OXY]- 2-METHYL-BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE -2- CARBOXIMIDAMID ZK-806711 INHIBITOR COMPLEX |
1qcp | CRYSTAL STRUCTURE OF THE RWJ-51084 BOVINE PANCREATIC BETA- TRYPSIN AT 1.8 A |
1ql7 | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
1ql8 | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
1rxp | STRUCTURE OF TRYPSIN (ORTHORHOMBIC) WITH 1-(4-TERT- BUTYLCARBAMOYL- PIPERAZINE-1-CARBONYL)-3-(3-GUANIDINO- PROPYL)-4-OXO-AZETIDINE-2-CARBOXYLIC ACID |
1s0q | NATIVE BOVINE PANCREATIC TRYPSIN |
1s0r | BOVINE PANCREATIC TRYPSIN INHIBITED WITH BENZAMIDINE ATATOMIC RESOLUTION |
1sbw | CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION |
1sfi | HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS |
1smf | TRYPSIN COMPLEXED WITH BOWMAN-BIRK INHIBITOR |
1tab | TRYPSIN COMPLEX WITH BOWMAN-BIRK INHIBITOR (AB-I) |
1taw | BOVINE TRYPSIN COMPLEXED TO APPI |
1tgb | TRYPSINOGEN-CA FROM PEG |
1tgc | TRYPSINOGEN (0.50 METHANOL, 0.50 WATER) |
1tgn | TRYPSINOGEN |
1tgs | TRYPSINOGEN COMPLEX WITH PORCINE PANCREATIC SECRETORY TRYPSIN INHIBITOR |
1tgt | TRYPSINOGEN (173 DEGREES K, 0.70 METHANOL, 0.30 WATER) |
1tio | HIGH PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE |
1tld | BETA-TRYPSIN (ORTHORHOMBIC) AT PH 5.3 |
1tng | TRYPSIN COMPLEXED WITH THE INHIBITOR AMINOMETHYLCYCLOHEXANE |
1tnh | TRYPSIN COMPLEXED WITH THE INHIBITOR 4-FLUOROBENZYLAMINE |
1tni | TRYPSIN COMPLEXED WITH THE INHIBITOR 4-PHENYLBUTYLAMINE |
1tnj | TRYPSIN COMPLEXED WITH THE INHIBITOR 2-PHENYLETHYLAMINE |
1tnk | TRYPSIN COMPLEXED WITH THE INHIBITOR 3-PHENYLPROPYLAMINE |
1tnl | TRYPSIN COMPLEXED WITH THE INHIBITOR TRANYLCYPROMINE |
1tpa | ANHYDRO-TRYPSIN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR |
1tpo | BETA-TRYPSIN (ORTHORHOMBIC) AT PH5.0 |
1tpp | BETA-TRYPSIN COMPLEX WITH P-AMIDINO-PHENYL-PYRUVATE ( APPA) |
1tps | TRYPSIN COMPLEXED WITH INHIBITOR A90720A |
1tx7 | BOVINE TRYPSIN COMPLEXED WITH P- AMIDINOPHENYLMETHYLPHOSPHINIC ACID (AMPA) |
1tx8 | BOVINE TRYPSIN COMPLEXED WITH AMSO |
1tyn | BETA TRYPSIN COMPLEXED WITH CYCLOTHEONAMIDE A |
1utn | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS |
1uto | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS |
1utp | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS |
1utq | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X -RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS |
1v2j | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X( SSRI)BT.C1 |
1v2k | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSINVARIANT X(TRIPLE.GLU)BT.D2 |
1v2l | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANTX( TRIPLE.GLU)BT.D1 |
1v2m | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANTX( TRIPLE.GLU)BT.A1 |
1v2n | POTENT FACTOR XA INHIBITOR IN COMPLEX WITH BOVINE TRYPSINVARIANT X(99/175/190)BT |
1v2o | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSYI)BT.B4 |
1v2p | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSYI)BT.A4 |
1v2q | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSWI)BT.B4 |
1v2r | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSRI)BT.B4 |
1v2s | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSFI .GLU)BT.D1 |
1v2t | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSFI.GLU)BT.B4 |
1v2u | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARINAT X( SSAI)BT.D1 |
1v2v | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X( SSAI)BT.C1 |
1v2w | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANTX(SSAI)BT.B4 |
1xuf | TRYPSIN-BABIM-ZN+2, PH 8.2 |
1xug | TRYPSIN-BABIM-ZN+2, PH 8.2 |
1xuh | TRYPSIN-KETO-BABIM-CO+2, PH 8.2 |
1xui | TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2 |
1xuj | TRYPSIN-KETO-BABIM-ZN+2, PH 8.2 |
1xuk | TRYPSIN-BABIM-SULFATE, PH 5.9 |
1y3u | TRYPSIN INHIBITOR COMPLEX |
1y3v | TRYPSIN INHIBITOR COMPLEX |
1y3w | TRYPSIN INHIBITOR COMPLEX |
1y3x | TRYPSIN INHIBITOR COMPLEX |
1y3y | TRYPSIN INHIBITOR COMPLEX |
1y59 | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT |
1y5a | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT |
1y5b | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT |
1y5u | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFICINHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT |
1yp9 | TRYPSIN INHIBITOR COMPLEX |
1yyy | TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES |
1zr0 | CRYSTAL STRUCTURE OF KUNITZ DOMAIN 1 OF TISSUE FACTORPATHWAY INHIBITOR-2 WITH BOVINE TRYPSIN |
1zzz | TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES |
2a7h | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULARCRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTIONWAVELENGTH |
2ah4 | GUANIDINOBENZOYL-TRYPSIN ACYL-ENZYME AT 1.13 A RESOLUTION |
2ayw | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TRYPSIN ANDA DESIGNED SYNTHETIC HIGHLY POTENT INHIBITOR IN THEPRESENCE OF BENZAMIDINE AT 0.97 A RESOLUTION |
2blv | TRYPSIN BEFORE A HIGH DOSE X-RAY "BURN" |
2blw | TRYPSIN AFTER A HIGH DOSE X-RAY "BURN" |
2btc | BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR ( CUCURBITA PEPO TRYPSIN INHIBITOR II) |
2by5 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION |
2by6 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION |
2by7 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION |
2by8 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION |
2by9 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION |
2bya | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION |
2bza | BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE |
2cmy | CRYSTAL COMPLEX BETWEEN BOVINE TRYPSIN AND VERONICA HEDERIFOLIA TRYPSIN INHIBITOR |
2fi3 | CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER, CYS38 ->SER) IN COMPLEX WITH TRYPSIN |
2fi4 | CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER) IN COMPLEXWITH TRYPSIN |
2fi5 | CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS38->SER) IN COMPLEXWITH TRYPSIN |
2ftl | CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BPTI AT 100K |
2ftm | CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH THE BPTIVARIANT (TYR35->GLY) |
2fx4 | BOVINE TRYPSIN BOUND BY 4-PIPERIDINEBUTYRATE TO MAKEACYLENZYME COMPLEX |
2fx6 | BOVINE TRYPSIN COMPLEXED WITH 2-AMINOBENZAMIDAZOLE |
2j9n | ROBOTICALLY HARVESTED TRYPSIN COMPLEXED WITH BENZAMIDINE CONTAINING POLYPEPTIDE MEDIATED CRYSTAL CONTACTS |
2ptc | BETA-TRYPSIN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR |
2ptn | TRYPSIN (ORTHORHOMBIC, 2.4 M AMMONIUM SULFATE) |
2tga | TRYPSINOGEN (2.4 M MAGNESIUM SULFATE) |
2tgd | TRYPSINOGEN, DIISOPROPYLPHOSPHORYL INHIBITED |
2tgp | TRYPSINOGEN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR |
2tgt | TRYPSINOGEN (103 DEGREES K, 0.70 METHANOL, 0.30 WATER) |
2tio | LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE |
2tld | BOVINE TRYPSIN COMPLEX WITH A MODIFIED SSI (STREPTOMYCES SUBTILISIN INHIBITOR) WITH MET 70 REPLACED BY GLY AND MET 73 REPLACED BY LYS (SSI(M70G,M73K)) |
2tpi | TRYPSINOGEN - PANCREATIC TRYPSIN INHIBITOR - ILE-VAL COMPLEX (2.4 M MAGNESIUM SULFATE) |
2uuy | STRUCTURE OF A TICK TRYPTASE INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN |
2xtt | BOVINE TRYPSIN IN COMPLEX WITH EVOLUTIONARY ENHANCED SCHISTOCERCA GREGARIA PROTEASE INHIBITOR 1 (SGPI-1-P02) |
3btd | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN THE BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI. |
3bte | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI. |
3btf | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI. |
3btg | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3bth | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3btk | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3btm | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3btq | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3btt | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3btw | THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI |
3ptb | BETA-TRYPSIN (BENZAMIDINE INHIBITED) AT PH7 |
3ptn | TRYPSIN (TRIGONAL, 2.4 M AMMONIUM SULFATE) |
3tpi | TRYPSINOGEN COMPLEX WITH PANCREATIC TRYPSIN INHIBITOR AND ILE-VAL |
4ab8 | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4aba | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4abb | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4abd | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4abe | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4abf | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4abg | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4abh | FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE |
4tpi | TRYPSINOGEN COMPLEX WITH THE ARG==15==-ANALOGUE OF PANCREATIC TRYPSIN INHIBITOR AND VAL-VAL |
5ptp | STRUCTURE OF HYDROLASE (SERINE PROTEINASE) |